MULTIPLE ASCENDING DOSE, OPEN-LABEL, PHASE 1/2 STUDY OF E6011, AN ANTI-FRACTALKINE MONOCLONAL ANTIBODY, TO INVESTIGATE THE SAFETY AND CLINICAL RESPONSE IN PATIENTS WITH CROHN'S DISEASE
Gastroenterology(2018)
摘要
Table 1.Patient characteristics of those who were dose increased vs
更多查看译文
关键词
crohn,monoclonal antibody,multiple ascending dose,open-label,anti-fractalkine
AI 理解论文
溯源树
样例
![](https://originalfileserver.aminer.cn/sys/aminer/pubs/mrt_preview.jpeg)
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要